A first research line is directed at the identification of new biomarkers that can be used for the early diagnosis and follow-up of cancer and other metabolic disorders. To achieve this goal, the research group relies on an NMR-based metabolomics approach, elegantly combining the available expertise regarding NMR spectroscopy with our broad interest in life sciences. 

A second research line is directed at the design and synthesis of protein-inspired biomaterials. Proteins and peptides are generated via recombinant DNA technologies or solid-phase peptide synthesis for a variety of applications including the regeneration of cartilage, the efficient transplantation of cardiac stem cells and the sealing of wounds. 

Protein-based materials are post-translationally modified via bio-orthogonal chemistries to tune the materials’ properties with respect to the intended application. BDG hereby focuses mainly on the optimisation of the materials’ mechanical properties as well as their biodegradability.